The SAE MOBILUS platform will continue to be accessible and populated with high quality technical content during the coronavirus (COVID-19) pandemic. x

Continuous Glucose Monitors (CGM), Proven Cost-Effective, Add to Quality of Life for Diabetics

  • Magazine Article
  • TBMG-29007
Published 2018-06-01 by Tech Briefs Media Group in United States
Annotation ability available
Sector:
Language:
  • English

Continuous glucose monitors (CGM) offer significant, daily benefits to people with type 1 diabetes, providing near-real time measurements of blood sugar levels, but they can be expensive. A new study by researchers from the University of Chicago Medicine, based on a six-month clinical trial, finds that use of a CGM is cost-effective for adult patients with type 1 diabetes when compared to daily use of test strips. The results are well within the thresholds normally used by insurance plans to cover medical devices. During the trial, CGMs improved overall blood glucose control for the study group and reduced hypoglycemia — low blood sugar episodes.